CRISPR-based Gene Editing

A Global Strategic Business Report

MCP30291

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

7052

EXECUTIVE POOL

5850

PRICE

811

EXPERT INPUTS

44

COMPANIES

98

DATA TABLES

172

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global CRISPR-based Gene Editing Market to Reach US$11.0 Billion by 2030

The global market for CRISPR-based Gene Editing estimated at US$4.4 Billion in the year 2024, is expected to reach US$11.0 Billion by 2030, growing at a CAGR of 16.3% over the analysis period 2024-2030. CRISPR Kits & Reagents, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$7.7 Billion by the end of the analysis period. Growth in the CRISPR Libraries segment is estimated at 12.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 15.3% CAGR

The CRISPR-based Gene Editing market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 15.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.3% and 13.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.7% CAGR.

Global CRISPR-Based Gene Editing Market – Key Trends & Drivers Summarized

Why Is CRISPR-Based Gene Editing Transforming Biotechnology? Exploring the Breakthroughs in Precision Medicine

The global CRISPR-based gene editing market has witnessed rapid expansion, driven by advancements in genetic engineering, increased funding for biotechnology research, and the growing demand for precision medicine. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has revolutionized the field of gene editing, enabling highly precise and efficient genetic modifications. The surge in gene therapy applications, aimed at treating genetic disorders such as sickle cell anemia, muscular dystrophy, and cystic fibrosis, has been a key driver of market growth. Additionally, CRISPR is playing an instrumental role in cancer immunotherapy, enabling the modification of immune cells to target tumors more effectively. With increasing interest in synthetic biology, CRISPR is also being utilized in the development of genetically engineered crops, microbial engineering for biofuel production, and disease-resistant livestock.

Which CRISPR-Based Applications Are Leading the Market? A Breakdown of Key Segments

The CRISPR-based gene editing market is segmented into therapeutic, agricultural, and industrial applications. The therapeutic segment, which includes gene therapy and regenerative medicine, dominates the market, as CRISPR is increasingly used to correct genetic mutations responsible for inherited diseases. Agricultural applications are also witnessing significant growth, with CRISPR being used to enhance crop yield, develop disease-resistant plants, and improve food security. The industrial biotechnology sector has also benefited from CRISPR, with applications in enzyme production, biofuel synthesis, and synthetic biology innovations. The emergence of CRISPR-based diagnostics, such as SHERLOCK and DETECTR, has further expanded the market’s scope by enabling rapid and cost-effective disease detection.

How Is Innovation Driving CRISPR-Based Gene Editing? The Role of AI, Nanotechnology & Bioinformatics

The CRISPR industry is evolving with the integration of artificial intelligence (AI), nanotechnology, and bioinformatics. AI-driven gene editing algorithms have enhanced precision, reducing the risk of off-target effects and improving editing efficiency. The development of next-generation Cas enzymes, such as Cas12 and Cas13, has expanded CRISPR’s capabilities beyond DNA editing to include RNA modifications. Nanotechnology-based CRISPR delivery systems, including lipid nanoparticles and viral vectors, are improving the efficiency and safety of gene-editing therapies. Additionally, advancements in bioinformatics tools are enabling researchers to model CRISPR interactions more accurately, optimizing gene-editing workflows. The rise of CRISPR-based epigenetic editing, which modifies gene expression without altering DNA sequences, has opened new possibilities for treating complex diseases.

What’s Driving the Growth of the CRISPR-Based Gene Editing Market? Key Market Influencers Explained

The growth in the CRISPR-based gene editing market is fueled by rising investment in biotechnology research, increasing applications in disease treatment, and advancements in delivery mechanisms. The expansion of gene therapy programs by pharmaceutical and biotech companies has strengthened the market’s commercial potential. Government funding initiatives and regulatory support for genome editing research have also accelerated innovation. The growing demand for personalized medicine, which leverages CRISPR to develop patient-specific treatments, has further boosted market growth. However, ethical concerns and regulatory scrutiny regarding human germline editing remain key challenges. With ongoing scientific advancements and broader acceptance of gene-editing applications, the CRISPR market is expected to witness transformative growth in the coming years.

SCOPE OF STUDY

The report analyzes the CRISPR-based Gene Editing market by the following Segments, and Geographic Regions/Countries:

Segments:

Products (CRISPR Kits & Reagents, CRISPR Libraries); Application (Biomedical Applications, Agricultural Applications); End-Use (Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use, Contract Research Organizations End-Use).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..

SELECT PLAYERS

Beam Therapeutics; Caribou Biosciences; Cellectis; Colossal Biosciences; CRISPR Therapeutics; Editas Medicine; eGenesis; Graphite Bio; Inari Agriculture; Inscripta; Intellia Therapeutics; Mammoth Biosciences; Pairwise; Poseida Therapeutics; Precision BioSciences; Sangamo Therapeutics; SNIPR Biome; Synthego Corporation; Tropic Biosciences; Verve Therapeutics

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

CRISPR-based Gene Editing – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 44 Players Worldwide in 2025 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Increasing Investment in Gene Therapy and Precision Medicine Spurs Market Growth for CRISPR-based Gene Editing

Surge in Biotechnology and Pharmaceutical Research Propels Demand for CRISPR as a Leading Gene Editing Tool

The Growing Need for Targeted and Personalized Treatments Expands Addressable Market for CRISPR Gene Editing Applications

Regulatory Advancements and Easing of Gene Editing Guidelines Accelerates the Commercialization of CRISPR-Based Therapies

The Expansion of Gene Therapy Clinical Trials Strengthens Business Case for CRISPR in Therapeutic Development

Rising Prevalence of Genetic Disorders and Chronic Diseases Drives Accelerated Adoption of CRISPR in Healthcare Solutions

Increasing Focus on Agricultural Biotechnology Strengthens the Case for CRISPR in Crop Improvement and Livestock Enhancement

Technological Advancements in CRISPR Delivery Mechanisms Propel Market Adoption in Both Clinical and Agricultural Sectors

The Shift Toward Sustainable Agriculture Drives Market Growth for CRISPR in Genetically Modified Crops with Enhanced Yield and Disease Resistance

Increased Investment in CRISPR Startups and Biotech Companies Spurs Innovation in Gene Editing Techniques

The Rise of CRISPR-Cas9-based Diagnostics and Point-of-Care Solutions Generates Demand for Gene Editing Technologies in Medical Devices

Public and Private Sector Collaborations and Funding Drive Growth in CRISPR-based Research and Development Projects

Regulatory and Ethical Challenges Surrounding Germline Editing Create Barriers to Market Growth in Certain Regions

Rising Demand for CRISPR in Cell and Gene Therapy Applications Expands Opportunities for Market Adoption in Regenerative Medicine

The Increasing Role of CRISPR in Infectious Disease Research and Treatment Drives New Opportunities in Global Health

Integration of CRISPR with AI and Machine Learning Strengthens the Business Case for Highly Targeted Gene Editing Solutions

Ethical Considerations and Public Perception of Gene Editing Technologies Throw the Spotlight on the Need for Responsible Innovation

Rising Demand for Non-invasive Gene Editing Solutions Spurs Growth in CRISPR-based Applications with Reduced Risk of Side Effects

The Need for Faster, More Accurate Genetic Research Drives Adoption of CRISPR in Academic and Commercial Research Laboratories

Advances in Genome Sequencing and Genomic Data Infrastructure Sustain Growth in the CRISPR-based Gene Editing Ecosystem

4. GLOBAL MARKET PERSPECTIVE

World CRISPR-based Gene Editing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for CRISPR-based Gene Editing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

World Recent Past, Current & Future Analysis for CRISPR Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for CRISPR Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for CRISPR Libraries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for CRISPR Libraries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Biomedical Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Biomedical Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Agricultural Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Agricultural Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

CRISPR-based Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

JAPAN

CRISPR-based Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

CHINA

CRISPR-based Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

EUROPE

CRISPR-based Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for CRISPR-based Gene Editing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

FRANCE

CRISPR-based Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

GERMANY

CRISPR-based Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

UNITED KINGDOM

CRISPR-based Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

ASIA-PACIFIC

CRISPR-based Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

REST OF WORLD

Rest of World Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Products - CRISPR Kits & Reagents and CRISPR Libraries - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for CRISPR-based Gene Editing by Products - Percentage Breakdown of Value Sales for CRISPR Kits & Reagents and CRISPR Libraries for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by Application - Biomedical Applications and Agricultural Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for CRISPR-based Gene Editing by Application - Percentage Breakdown of Value Sales for Biomedical Applications and Agricultural Applications for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for CRISPR-based Gene Editing by End-Use - Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for CRISPR-based Gene Editing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic & Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll